Literature DB >> 21049348

Evaluation of lexically and nonlexically based reading treatment in a deep dyslexic.

Nicole Stadie1, Eva Rilling.   

Abstract

The aim of the single case study was to evaluate two different treatment procedures to improve reading skills with a German-speaking deep dyslexic. Generally, in treatment studies for deep dyslexia, retraining of grapheme-phoneme correspondences is described, but hardly any treatment focuses on reactivating residual functions of the semantic-lexical route. This strategy was explored here with an experimentally presented priming paradigm, to implicitly strengthen residual skills of lexical access with semantically/phonologically related primes (lexically based treatment). In contrast, grapheme-phoneme associations and blending were explicitly relearned during a nonlexically based treatment. Stimuli were controlled for part of speech, word length, and frequency. A cross-over design to identify item- and treatment-specific effects for both procedures was applied. Results indicate positive outcomes with respect to treatment-specific effects for both procedures, generalization to untrained items, and a transfer task after the nonlexically based procedure. All effects remained stable in the follow-up assessment. Implications for theoretically/empirically generated expectations about treatment outcomes are discussed.

Entities:  

Year:  2006        PMID: 21049348     DOI: 10.1080/02643290500538364

Source DB:  PubMed          Journal:  Cogn Neuropsychol        ISSN: 0264-3294            Impact factor:   2.468


  2 in total

Review 1.  Connectionist neuropsychology: uncovering ultimate causes of acquired dyslexia.

Authors:  Anna M Woollams
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-12-09       Impact factor: 6.237

2.  Randomized trial of iReadMore word reading training and brain stimulation in central alexia.

Authors:  Zoe V J Woodhead; Sheila J Kerry; Oscar M Aguilar; Yean-Hoon Ong; John S Hogan; Katerina Pappa; Alex P Leff; Jennifer T Crinion
Journal:  Brain       Date:  2018-07-01       Impact factor: 13.501

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.